Screener
Gyre Therapeutics, Inc. GYRE Gyre — Interest Income Expense Net
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | Three Months Ended June 30, | Six Months Ended June 30, |
|---|---|---|
| Total operating expenses | 31,974 | 60,003 |
| (Loss) income from operations | (2,240)) | 302) |
| Other (loss) income, net: | ||
| Interest income | 941 | 1,797 |
| Other expense, net | (488)) | (301)) |
| Change in fair value of warrant liability | 212 | 2,467 |
| (Loss) Income before income taxes | (1,575)) | 4,265) |
| Benefit (provision) for income taxes | (662) | (1,563)) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s gyre — interest income expense net?
- Gyre Therapeutics, Inc. (GYRE) reported gyre — interest income expense net of $488K in Q2 2026.
- How has Gyre Therapeutics, Inc.'s gyre — interest income expense net changed year-over-year?
- Gyre Therapeutics, Inc.'s gyre — interest income expense net decreased by 27.2% year-over-year, from $670K to $488K.
- What does gyre — interest income expense net mean?
- This metric represents the net balance of interest income earned on cash and investments versus interest expense incurred on debt obligations specifically attributed to the segment. It highlights the segment's net financing cost or return on its internal capital structure. A positive value indicates the segment is a net generator of interest income, while a negative value indicates a net cost of capital.
Ask your AI about Gyre Therapeutics, Inc.'s gyre — interest income expense net.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude